| Name | 4-Hydroxytamoxifen |
| Description | 4-Hydroxytamoxifen (ICI 79280) is the active metabolite of Tamoxifen, an estrogen receptor modulator (SERM) with selective and oral potency. 4-Hydroxytamoxifen has antitumor activity and may be used in breast cancer research. |
| Kinase Assay | Cytosol (200 μL) is incubated for 30 min at 4°C with different concentrations of oestradiol, tamoxifen and (4-Hydroxytamoxifen) or dihydroxytamoxifen administered in 10 μL methanol. Control tubes are incubated with 10 μL methanol alone and non-specific binding is determined in a parallel incubation of cytosol (200 μL) with methanol (10 μL) containing DES (5 × 106 M). [2,4,6,7-3H]Oestradiol solution (50 μL) in TED buffer is added to each tube to give a final concentration of 2 × 10-9 M. Incubation is continued for 4 h (4°C) and then 400 μL of a suspension of dextran-coated charcoal (250 mg % Norit A, 2.5 mg % dextran) in TED buffer is added and allowed to stand for 20 min. Tubes are centrifuged at 800 g for 10 min (4°C) and 400 μL samples of the supernatant are added to 10 mL tritium scintillator (6 g butyl PBD, 135 mL toluene, 720 ml dioxane, 100 g naphthalene, 45 mL absolute methanol). Samples are counted for 10 min in a liquid scintillation spectrometer. Counting efficiency is determined by external standardization (35-36 %). Results are represented as a percentage of the specifically bound radioactivity (c.p.m.) in the control tubes[1]. |
| Animal Research | 4-Hydroxytamoxifen is formulated in sesame oil[3].Animals of each sex are divided into two groups: one group receives 4-Hydroxytamoxifen [6 μg/0.1 mL sesame oil/day, subcutaneously (s.c.) starting at 06.00 h] injections for three consecutive days, while the other group receives an equivalent amount of sesame oil injection for 3 days. Four hours following the third injection, each group is then subdivided into two groups: one receives four cumulative doses of methamphetamine hydrochloride (10 mg/kg, s.c.), and the other receives a comparable volume of saline at 2-h intervals. Bilateral gonadectomy is performed under pentobarbital anesthesia (50 mg/kg, intraperitoneally). Five weeks after surgery, gonadectomized mice of each sex are randomly divided into six groups. Five groups of each sex receive three daily injections of various concentrations of 4-Hydroxytamoxifen (0, 1.5, 3.0, 6.0, and 12.0 μg/0.1 mL sesame oil/day). Four hours following the third injection, mice receive four doses of methamphetamine (MA, 10 mg/kg) at 2-h intervals. The remaining group of each sex receives sesame oil pretreatment for three consecutive days, followed by saline injections, and serves as the control group[3]. |
| In vitro | 方法：人子宫内膜腺癌细胞系 HEC-1B 用 4-Hydroxytamoxifen (0.01-100 µM) 处理 3 天，使用 CellTiter 96 AQueous One Solution Cell Proliferation Assay 检测细胞活力。
结果：暴露于更高浓度 (1-100 µM) 的 4-Hydroxytamoxifen 的 HEC-1B 细胞显示出不同浓度之间细胞存活率的显著差异。[1]
方法：ER-阳性乳腺癌症细胞系 MCF-7、T47D 和 BT-474 用 4-Hydroxytamoxifen (0.5-1 µM) 和 sulforaphane (5 µM) 处理 48 h，使用 Western Blot 检测靶点蛋白表达水平。
结果：Sulforaphane 诱导 PARP 切割，其强度取决于细胞系。sulforaphane 和 4-Hydroxytamoxifen 的联合治疗进一步提高了 PARP 的切割。[2] |
| In vivo | 方法：为检测体内抗肿瘤活性，将 Cholesterol (1 mg/kg) 腹腔注射给携带人乳腺癌肿瘤 MCF-7 的 Nu/Nu 小鼠，每天一次，持续二十三天。
结果：4-Hydroxytamoxifen 有效地抑制小鼠的肿瘤生长。[3]
方法：为诱导 Cre 重组酶活性，将 Cholesterol (30-60 mg/kg) 腹腔注射给 Rosa26BEST1-CreERT2 小鼠，每天一次，持续四天。
结果：TdTomato 在两性小鼠的 RPE 中强烈表达。[4] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : < 0.1 mg/mL (insoluble)
DMSO : 45 mg/mL (116.13 mM)
|
| Keywords | inhibit | Estrogen Receptor/ERR | 4-hydroxy Tamoxifen | estrogen receptor | oral | CRISPR/Cas9 | ICI79280 | 4-Hydroxytamoxifen | 4Hydroxytamoxifen | Inhibitor | (Z)-Afimoxifene | nucleus translocation | 4 Hydroxytamoxifen | ICI-79280 |
| Inhibitors Related | Astragaloside IV | Estradiol | Melatonin | Mifepristone | Ethisterone | Kaempferol | Cholesterol |
| Related Compound Libraries | Anti-Cancer Active Compound Library | Bioactive Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | ReFRAME Related Library | Endocrinology-Hormone Compound Library | Anti-Ovarian Cancer Compound Library | NO PAINS Compound Library | Orally Active Compound Library | Human Metabolite Library |
